Erasca Inc. (ERAS) is priced at $13.37 after the most recent trading session. At the very opening of the session, the stock price was $12.77 and reached a high price of $14.425, prior to closing the session it reached the value of $12.55. The stock touched a low price of $12.35.Recently in News on January 4, 2022, Erasca to Present at the 40th Annual J.P. Morgan Healthcare Conference. Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the 40th annual J.P. Morgan Healthcare Conference. Jonathan E. Lim, M.D., chairman, CEO, and co-founder, will present an overview of the company and pipeline at 3:45 pm Eastern Time on Monday, January 10, 2022. Dr. Lim and David M. Chacko, M.D., chief financial officer, will also participate in one-on-one investor meetings. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Erasca Inc. shares are logging -45.36% during the 52-week period from high price, and 14.71% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $11.65 and $24.47.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1319073 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Erasca Inc. (ERAS) recorded performance in the market was -14.18%, having the revenues showcasing -25.80% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.68B, as it employees total of 102 workers.
Analysts verdict on Erasca Inc. (ERAS)
During the last month, 0 analysts gave the Erasca Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 18.01, with a change in the price was noted -7.60. In a similar fashion, Erasca Inc. posted a movement of -36.24% for the period of last 100 days, recording 394,736 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ERAS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Erasca Inc. (ERAS): Technical Analysis
Raw Stochastic average of Erasca Inc. in the period of last 50 days is set at 19.17%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 39.43%. In the last 20 days, the company’s Stochastic %K was 21.22% and its Stochastic %D was recorded 18.03%.
Let’s take a glance in the erstwhile performances of Erasca Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -14.18%. The shares increased approximately by 1.67% in the 7-day charts and went up by -4.50% in the period of the last 30 days. Common stock shares were lifted by -25.80% during last recorded quarter.